This is a demo store. No orders will be fulfilled.
Vital Signs - The Analyst's Perspective - May 2015 Issue
Vital Signs - The Analyst's Perspective - May 2015 Issue
RELEASE DATE
30-Jun-2015
30-Jun-2015
REGION
Asia Pacific
Asia Pacific
Research Code: 9A35-00-37-00-00
SKU: HC02614-AP-MR_16736
$450.00
In stock
SKU
HC02614-AP-MR_16736
Description
This issue of Vital Signs, released on June 8, 2015, discusses cholesterol lowering drugs from Amgen and Sanofi/Regeneron, LabCorp's new offering of direct-to-consumer testing, Apple's foray into collecting genetic information from users, and Danaher's acquisition of Pall.
Table of Contents
This month's issue
Popular Topics
This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclinical trials to post-marketing surveillance. It provides detailed information on support services, such as central laboratory services, bio-analytics, and data management. The market insight also analyses Market Engineering measurements, and R&D trends.
No Index | No |
---|---|
Podcast | No |
Author | Christi Bird |
Industries | Healthcare |
WIP Number | 9A35-00-37-00-00 |
Is Prebook | No |